This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Will Colgate (CL) Retain Earnings Trend in Q4 Despite Odds?
by Zacks Equity Research
Colgate (CL) witnesses soft top line and strained margins, owing to tough operating environment and higher costs. However, its beat or meet earnings trend is likely to continue in fourth-quarter 2018.
Colgate-Palmolive (CL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Procter & Gamble (PG) Retain Earnings Beat Trend in Q2?
by Zacks Equity Research
Procter & Gamble's (PG) strategic efforts such as product improvement and cost-saving plans are impressive. However, commodity cost inflation and adverse currency remain concerns.
5 Consumer Staples Stocks Set to Top Earnings Estimates in Q4
by Zacks Equity Research
There are various players in the consumer staples space that appear lucrative this earnings season, thanks to their efforts to counter the odds.
The Zacks Analyst Blog Highlights: Morgan Stanley, Intuitive Surgical, Colgate-Palmolive, Keurig Dr Pepper and Prudential Financial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Morgan Stanley, Intuitive Surgical, Colgate-Palmolive, Keurig Dr Pepper and Prudential Financial
Top Research Reports for Morgan Stanley, Intuitive Surgical & Colgate-Palmolive
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, Morgan Stanley (MS), Intuitive Surgical, Inc. (ISRG) and Colgate-Palmolive Company (CL).
Colgate Stock Loses Ground: Can Strategies Aid a Turnaround?
by Zacks Equity Research
Colgate's (CL) grapples with soft sales and strained margins for quite a while now. Nevertheless, the company's cost-savings program appears promising.
Clorox's (CLX) 2020 Strategy on Track, Margin Woes Linger
by Zacks Equity Research
Clorox (CLX) benefits from 2020 strategy, expansion of e-commerce capabilities and brand management initiatives. However, dismal margins and soft fiscal earnings view are concerns.
Forget Colgate, Buy These 4 Consumer Stocks Instead for 2019
by Rajani Lohia
Colgate (CL) suffers due to higher raw material and freight costs as well as unfavorable currency rates. However, there are other stocks that are poised to benefit from favorable consumer trends.
Amedisys, Colgate-Palmolive, Deutsche, Societe General and Danske highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Amedisys, Colgate-Palmolive, Deutsche, Societe General and Danske highlighted as Zacks Bull and Bear of the Day
Colgate (CL) Stock Down 14.3% YTD: What You Should Know
by Zacks Equity Research
Colgate's (CL) dismal performance can be attributed to uncertain global markets. Also, a dismal sales trend is worrisome. However, the company's savings programs appear impressive.
Bear of the Day: Colgate-Palmolive (CL)
by Madeleine Johnson
Earnings estimated have fallen sharply for this consumer staples giant.
New Strong Sell Stocks for November 27th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Why Is Colgate-Palmolive (CL) Down 3.2% Since Last Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for October 31st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Company News For Oct 29, 2018
by Zacks Equity Research
Companies In The News Are: GOOGL, INTC, CL, CMG
Imports Boost Q3 GDP
by Zacks Equity Research
Imports Boost Q3 GDP
Q3 GDP Reaches 3.5% on Big Import Growth
by Mark Vickery
3.5% Q3 GDP on the headline was better by 20-30 basis points from analyst consensus, though lower than Q2's unrevised 4.2% growth in the June quarter.
Colgate's (CL) Q3 Earnings In Line, Sales Miss Estimates
by Zacks Equity Research
Colgate (CL) posts in-line earnings in third-quarter 2018 with a top line miss. Also, it expects a challenging backdrop moving ahead.
Colgate-Palmolive (CL) Q3 Earnings Meet Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0.00% and -0.81%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Things You Need to Know Before Colgate's (CL) Q3 Earnings
by Zacks Equity Research
Colgate (CL) is progressing well with its Global Growth and Efficiency Program. However, it witnesses strained margins due to higher raw material and packaging costs.
Colgate-Palmolive (CL) Q3 Earnings Preview: What to Look Out For
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Soap & Cleaning Materials Stock Outlook: Near-Term Picture Drab
by Zacks Equity Research
Intense competition as well as increased raw material, transportation and packaging costs are impacting Soap and Cleaning Materials industry, resulting in bleak near-term prospects.
New Strong Sell Stocks for August 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Market News For Jul 30, 2018
by Zacks Equity Research
Companies in the news are: CL, SBUX, SAM and EXPE